-+ 0.00%
-+ 0.00%
-+ 0.00%

Qiagen targets about 7% constant-currency sales CAGR through 2028

PUBT·08/27/2026 14:47:32
Listen to the news
Qiagen targets about 7% constant-currency sales CAGR through 2028
  • Qiagen set 2028 targets of about 7% constant-exchange-rate net sales CAGR from 2024-28, with adjusted operating income margin at least 31%.
  • Strategy calls for at least $2 billion of 2028 net sales at constant exchange rates from growth pillars, supported by efficiency and digitization.
  • Plan targets at least 250 basis points of adjusted operating margin expansion from 2024-28.
  • Capital allocation framework includes at least $1 billion of shareholder returns from 2024-28, excluding M&A.
  • Product targets include at least $250 million 2028 net sales for QIAcuity dPCR, at least $200 million for QIAstat-Dx.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qiagen NV published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.